TNXP — Tonix Pharmaceuticals Holding Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Tonix Pharmaceuticals Holding, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	179	120	24.9	98.8	208
Net Total Accounts Receivable
Net Total Receivables	—	—	—	4.82	6.27
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	189	131	47.8	119	229
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	51.5	94.5	94.9	42.8	46
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	241	226	154	163	277
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21.7	18.2	18.9	18.3	30.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.2	18.5	48.9	23.3	32
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	219	207	106	140	245
Total Liabilities & Shareholders' Equity	241	226	154	163	277
Total Common Shares Outstanding